Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3Weight Loss 1SCLC, Limited Stage 1Pediatric Obesity 1Pain, Postoperative 1Obesity 1Neoplasms 1Multiple Myeloma 1Liver Neoplasms 1Laryngeal Neoplasms 1Gynecologic Oncology Patient 1Emotional Regulation 1Cognitive Dysfunction 1Anxiety Disorders 1

Interventions

Fulvestrant 125Trastuzumab 114Paclitaxel 113Letrozole 108pembrolizumab 79pertuzumab 75palbociclib 75Capecitabine 72Anastrozole 72Cyclophosphamide 70Carboplatin 67abemaciclib 64exemestane 63Tamoxifen 63ribociclib 60trastuzumab deruxtecan 57Surveys and Questionnaires 51Specimen Handling 50Radiotherapy 49Docetaxel 49Magnetic Resonance Spectroscopy 48Blood Specimen Collection 40olaparib 39Standard of Care 36Biopsy 33sacituzumab govitecan 31130-nm albumin-bound paclitaxel 31Doxorubicin 30Exercise 29eribulin 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Breast Neoplasms × Population Groups × 1 year × Clear all
NCT05984888 2025-10-03

MIND-BC

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
43 enrolled
Breast

Breast Neoplasms

NCT06676228 2025-10-02

Fear of Cancer Recurrence Therapy (FORT): Turkish Cultural Adaptation and Implementation Project

Maltepe University

Phase NA Completed
100 enrolled
Breast

Anxiety Disorders, Breast Neoplasms

NCT07077018 2025-07-22

Fasting-Mimicking Diet as an Adjunct to Neoadjuvant Chemotherapy for Hormone-Receptor-Positive Breast Cancer

Guangdong Provincial People's Hospital

Phase NA Not yet recruiting
45 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡